Inflation data to be released on Thursday will offer the latest gauge of prices a day after President Donald Trump paused ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

S&P/TSX Composite Index 23,135.33-591.70-2.49% ...